Gene · 8685
Papers1,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Signatures Associated with Pterygium Recurrence. | J Clin Med | 2026 | 42796028 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis indicates MARCO and ZBTB20 as candidate biomarkers in rheumatoid arthritis and tuberculosis. | Front Immunol | 2026 | 42741539 | PubTator, text mining | PubMed |
| The light side of mast cell degranulation: delivering macrophage repair through molecular condensates. | J Leukoc Biol | 2026 | 42740557 | PubTator, text mining | PubMed |
| A serpin-myeloid axis in pancreatic cancer heterogeneity and immune evasion. | Nature | 2026 | 42717081 | PubTator, text mining | PubMed |
| Spatial transcriptomics and histopathological analyses reveal potential biomarkers and immune features linked to recurrence in head and neck cancer. | Front Immunol | 2026 | 42643341 | PubTator, text mining | PubMed |
| MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling. | Immunobiology | 2026 | 42628137 | PubTator, text mining | PubMed |
| Correction for Yang et al., Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression. | Proc Natl Acad Sci U S A | 2026 | 42607226 | PubTator, text mining | PubMed |
| Cancer immunotherapy targeting murine myeloid cells requires endosomal pattern recognition. | Nat Commun | 2026 | 42509237 | PubTator, text mining | PubMed |
| Integrated spatially guided transcriptomics and multiplex imaging identify a high-risk CD163+/CD11c-subgroup in diffuse large B-cell lymphoma. | Haematologica | 2026 | 42489074 | PubTator, text mining | PubMed |
| A nerve and mast cell sentinel system releases extracellular condensates to induce macrophage repair. | J Exp Med | 2026 | 42484560 | PubTator, text mining | PubMed |
| Plasma Proteomic Profiling Identifies Candidate Biomarkers for Pancreatic Ductal Adenocarcinoma. | J Clin Lab Anal | 2026 | 42482375 | PubTator, text mining | PubMed |
| Mining and experimental validation of machine learning-based immune-related diagnostic biomarkers for hepatocellular carcinoma. | J Gastrointest Oncol | 2026 | 42434259 | PubTator, text mining | PubMed |
A transcriptome-defined TAM-rich phenotype identifies a macrophage-enriched, hypoxia-linked immune contexture in glioblastoma: multi-cohort transcriptomic validation and local histopathological correlation. | Front Immunol | 2026 | 42389535 | PubTator, text mining | PubMed |
| HMPV Impairs Macrophage Phagocytosis Through a Replication-Dependent Mechanism Associated with Reduced CD36 Expression and the Viral G Protein. | Viruses | 2026 | 42357659 | PubTator, text mining | PubMed |
| Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line. | Stem Cell Res | 2026 | 42214129 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Spatial Transcriptomics Analyses Delineate a BAG3-Associated Macrophage Program with Microenvironmental and Prognostic Relevance in Hepatocellular Carcinoma. | Genes (Basel) | 2026 | 42195019 | PubTator, text mining | PubMed |
| Paired Tumor Biopsies Reveal Spatiotemporal Myeloid Remodeling After Local Chemotherapy in Glioblastoma. | bioRxiv | 2026 | 42182459 | PubTator, text mining | PubMed |
| Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma. | J Immunother Cancer | 2026 | 42161402 | PubTator, text mining | PubMed |
| CCR1+ monocytes facilitating bronchopulmonary dysplasia through regulation of S100A8 and MMP8. | Front Immunol | 2026 | 42148139 | PubTator, text mining | PubMed |
| A Matrix-Free 3D Hepatocyte-Macrophage Co-Culture Spheroid Model for Dual Assessment of Lipid Accumulation and NF-κB-Mediated Inflammatory Activation Under Glucolipotoxic Stress. | Biomedicines | 2026 | 42072333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8685/papers